Media Summary: Speaker: Meisam Naeimi, DVM, PhD In this Webinar, You Will Learn: The importance of John Maher, BA, MBBCh, BAO, MRCPI, MRCP, MSc, FRCPath, King's College London, London, UK, talks on the potential of ... Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, shares an update on the latest developments regarding ...

Developing Off The Shelf Car - Detailed Analysis & Overview

Speaker: Meisam Naeimi, DVM, PhD In this Webinar, You Will Learn: The importance of John Maher, BA, MBBCh, BAO, MRCPI, MRCP, MSc, FRCPath, King's College London, London, UK, talks on the potential of ... Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, shares an update on the latest developments regarding ... Dr Velamehr presents data at AACR about the production of chimeric antigen recombinant ( Find out what drove John McKearn, Ph.D. & CEO at Wugen, out of the lab at Pfizer and on to his quest to Jae Park, MD, a hematologist oncologist at Memorial Sloan Kettering Cancer Center, discusses the benefits of

MD Anderson and Takeda Pharmaceutical Company Limited have announced an exclusive license agreement and research ... 안녕하세요. KOBRA 첨단바이오 연구센터입니다. 2025년 11월 17일, 서울대학교 의과대학에서는 'Double-negative T cells ... Adam Sperling, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, reflects on allogeneic and Stephan Grupp, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, discusses the potential of having " On this episode of Better Biopharma, Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D., explain how the company ... 워크샵 소개 'Double-negative T cells (DNTs)'는 CD4 CD8 수용체가 모두 결여된 T 세포로, 면역조절 및 항암치료에서 새로운 축으로 ...

Ritwika Biswas, Product Scientist for Sino Biological, talks In this discussion, David Sallman, MD, Moffitt Cancer Center, Tampa, FL, Tim Sauer, MD, Heidelberg University Hospital, ... Two 7 Second Turbo Audi R8s from Development !!!

Photo Gallery

Cell Therapy: Off-the-Shelf CAR γδT Cells Generated Using CRISPR/AAV
Generating off-the-shelf CAR-Ts with iPSCs
Developing off-the-shelf CAR T-cells to treat multiple myeloma
Developing off-the-shelf CAR T cells with stem cell libraries
Allogeneic CAR-T Therapy: Understanding This New Approach in Myeloma Immunotherapy
Off-The-Shelf CAR T-Cell Therapy?
Dr. Park on the Benefits of Off-the-Shelf CAR T-Cell Therapy in ALL
MD Anderson and Takeda announce collaboration to develop off-the-shelf CAR NK-cell therapies
Building "Off-the-Shelf" CAR T-cells - Sidharth Raghavan
Workshops Review] Developing Off-the-Shelf CAR-T cell Therapy Using Double-Negative T cell
Challenges associated with the use of off-the-shelf CAR-T products in multiple myeloma
"Off-the-shelf" CAR-T: future prospects
Sponsored
Sponsored
View Detailed Profile
Cell Therapy: Off-the-Shelf CAR γδT Cells Generated Using CRISPR/AAV

Cell Therapy: Off-the-Shelf CAR γδT Cells Generated Using CRISPR/AAV

Speaker: Meisam Naeimi, DVM, PhD In this Webinar, You Will Learn: The importance of

Generating off-the-shelf CAR-Ts with iPSCs

Generating off-the-shelf CAR-Ts with iPSCs

John Maher, BA, MBBCh, BAO, MRCPI, MRCP, MSc, FRCPath, King's College London, London, UK, talks on the potential of ...

Sponsored
Developing off-the-shelf CAR T-cells to treat multiple myeloma

Developing off-the-shelf CAR T-cells to treat multiple myeloma

Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, shares an update on the latest developments regarding ...

Developing off-the-shelf CAR T cells with stem cell libraries

Developing off-the-shelf CAR T cells with stem cell libraries

Dr Velamehr presents data at AACR about the production of chimeric antigen recombinant (

Allogeneic CAR-T Therapy: Understanding This New Approach in Myeloma Immunotherapy

Allogeneic CAR-T Therapy: Understanding This New Approach in Myeloma Immunotherapy

Allogeneic

Sponsored
Off-The-Shelf CAR T-Cell Therapy?

Off-The-Shelf CAR T-Cell Therapy?

Find out what drove John McKearn, Ph.D. & CEO at Wugen, out of the lab at Pfizer and on to his quest to

Dr. Park on the Benefits of Off-the-Shelf CAR T-Cell Therapy in ALL

Dr. Park on the Benefits of Off-the-Shelf CAR T-Cell Therapy in ALL

Jae Park, MD, a hematologist oncologist at Memorial Sloan Kettering Cancer Center, discusses the benefits of

MD Anderson and Takeda announce collaboration to develop off-the-shelf CAR NK-cell therapies

MD Anderson and Takeda announce collaboration to develop off-the-shelf CAR NK-cell therapies

MD Anderson and Takeda Pharmaceutical Company Limited have announced an exclusive license agreement and research ...

Building "Off-the-Shelf" CAR T-cells - Sidharth Raghavan

Building "Off-the-Shelf" CAR T-cells - Sidharth Raghavan

Sidharth presents on Building "

Workshops Review] Developing Off-the-Shelf CAR-T cell Therapy Using Double-Negative T cell

Workshops Review] Developing Off-the-Shelf CAR-T cell Therapy Using Double-Negative T cell

안녕하세요. KOBRA 첨단바이오 연구센터입니다. 2025년 11월 17일, 서울대학교 의과대학에서는 'Double-negative T cells ...

Challenges associated with the use of off-the-shelf CAR-T products in multiple myeloma

Challenges associated with the use of off-the-shelf CAR-T products in multiple myeloma

Adam Sperling, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, reflects on allogeneic and

"Off-the-shelf" CAR-T: future prospects

"Off-the-shelf" CAR-T: future prospects

Stephan Grupp, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, discusses the potential of having "

Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

On this episode of Better Biopharma, Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D., explain how the company ...

From Exclusive to Accessible: Developing Off-the-Shelf CAR-T cell Therapy Using DNTs

From Exclusive to Accessible: Developing Off-the-Shelf CAR-T cell Therapy Using DNTs

워크샵 소개 'Double-negative T cells (DNTs)'는 CD4·CD8 수용체가 모두 결여된 T 세포로, 면역조절 및 항암치료에서 새로운 축으로 ...

Universal “off-the-shelf” CAR T-cells from iPSCs

Universal “off-the-shelf” CAR T-cells from iPSCs

Current

CAR T-Cell Therapy: How Does It Work?

CAR T-Cell Therapy: How Does It Work?

CAR

CAR-T Cell Therapy Development: From Personalized to off the Shelf Approaches

CAR-T Cell Therapy Development: From Personalized to off the Shelf Approaches

Ritwika Biswas, Product Scientist for Sino Biological, talks

Cellular therapy approaches in AML: novel targets, off-the-shelf CARs, & NK-cell therapy

Cellular therapy approaches in AML: novel targets, off-the-shelf CARs, & NK-cell therapy

In this discussion, David Sallman, MD, Moffitt Cancer Center, Tampa, FL, Tim Sauer, MD, Heidelberg University Hospital, ...

Two 7 Second Turbo Audi R8s from @T1Race Development !!!

Two 7 Second Turbo Audi R8s from @T1Race Development !!!

Two 7 Second Turbo Audi R8s from @T1Race Development !!!

Off-the-shelf CAR-T for T-cell malignancies: UCART3

Off-the-shelf CAR-T for T-cell malignancies: UCART3

While